[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336256-105":59,"doc-detail-336256-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","non-hypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias","Non-hypermutator cancers access driver mutations through reversals in germline mutational bias","","Cancer evolves through DNA mutations in asexually reproducing somatic cells, and mutation-supply dynamics are shaped by both mutation rates and mutation-spectrum biases. By analyzing tumor samples from 20 tissues alongside corresponding normal tissue and germline data, this work shows that non-hypermutated tumors reverse the germline mutation bias and maintain consistent spectra across tissues. Spectrum changes bear the signature of hypoxia and enable positive selection in cancer genes, yielding distinct routes to driver mutations for hypermutated versus non-hypermutated cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-hypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias/336256/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-hypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias/336256.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What relationship between mutation rate and mutation spectrum is examined in this study?","Question",{"text":112,"@type":113},"The study evaluates how changes in mutation spectrum interact with mutation rate to shape cancer evolutionary trajectories and driver-mutation access.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What distinguishes non-hypermutated tumors from hypermutated tumors in acquiring driver mutations?",{"text":117,"@type":113},"Hypermutated tumors gain driver mutations largely through higher mutation rates, while non-hypermutated tumors gain them through mutation-spectrum changes that reverse the germline mutation bias.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the mutation spectra of non-hypermutated tumors behave across tissues?",{"text":121,"@type":113},"Non-hypermutated tumors show a highly conserved mutation spectrum across tissues that consistently reverses the germline mutation bias.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336256,1790153391,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","bioRxiv preprint doi: [https://doi.org/10.1101/2024.04.30.591900](https://doi.org/10.1101/2024.04.30.591900); this version posted May 3, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-ND 4.0 International license.  \nNon-hypermutator cancers access driver mutations through reversals in germline mutational bias  \nMarwa Z. Tuffaha, 1 David Castellano,2 Claudia Serrano Colome,3 Ryan N. Gutenkunst,2 Lindi M. Wahl 1 ,∗  \n1Department of Mathematics, Western University,  \nLondon, Ontario N6A 5B7, Canada  \n2Department of Molecular and Cellular Biology, University of Arizona,  \nTucson, Arizona 85721, USA  \n3 Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain.  \n∗ Corresponding author: [lwahl@uwo.ca](lwahl@uwo.ca).  \nCancer is an evolutionary disease driven by mutations in asexually-reproducing somatic cells. In asexual microbes, bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations. By analyzing tumors from 20 tissues, along with normal tissue and the germline, we demonstrate this effect in cancer. Non-hypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues.  \nThese spectra changes carry the signature of hypoxia, and they facilitate positive selection in cancer genes. Hypermutated and non-hypermutated tumors thus acquire driver mutations differently: hypermutated tumors by higher mutation rates and non-hypermutated tumors by changing the mutation spectrum to reverse the germline mutation bias.  \nbioRxiv preprint doi: [https://doi.org/10.1101/2024.04.30.591900](https://doi.org/10.1101/2024.04.30.591900); this version posted May 3, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-ND 4.0 International license.  \nIntroduction  \nCancer is an evolutionary disease arising from DNA mutations that allow cells to proliferate abnormally and invade surrounding tissues and other organs (1) . During the asexual reproduction of normal somatic cells, de novo mutations accumulate through time, leading to an increased risk of cancer with age (2) . Cancer develops when mutations in specific genes or combinations of genes (so-called “cancer genes”) impair normal cell function by, for example, deactivating cell cycle checkpoints or by activating cell signaling pathways that favour cell division (3) .  \nThe supply of mutations is a key factor underpinning evolutionary trajectories (4), and is especially important in asexual reproduction, where recombination is reduced or absent (5) . In microbial evolution, lineages with an increased mutation rate (mutators) frequently emerge due to their improved access to rare beneficial mutations (6) . Along with increases in mutation rate, changes in mutation spectra also affect mutational supply (7–9) . We previously demonstrated that the interaction between mutation rate and spectrum powerfully influences the evolutionary trajectory of asexual populations (10) . Simply put, previously undersampled mutations maybe reached by either making more mutations (mutation rate elevation, fig. 1A), or by making different mutations (mutation spectrum change, fig. 1B) . If mutations have historically occurred with some bias (undersampling some classes of mutations while oversampling others), reversing this bias affords access to mutations that were previously unlikely to have occurred, such asundersampled beneficial mutations (9) .  \nCancer is a set of diseases that have similar hallmarks, but there are many differences between cancer types, including different mutational processes and rates (11) . Broadly sp","cbCaifSdWnQYgp7m","https://ap.wps.com/l/cbCaifSdWnQYgp7m","pdf",393625,"English","# Introduction\n# Results\n## Reduced transition bias in non-hypermutated samples","[{\"question\":\"What relationship between mutation rate and mutation spectrum is examined in this study?\",\"answer\":\"The study evaluates how changes in mutation spectrum interact with mutation rate to shape cancer evolutionary trajectories and driver-mutation access.\"},{\"question\":\"What distinguishes non-hypermutated tumors from hypermutated tumors in acquiring driver mutations?\",\"answer\":\"Hypermutated tumors gain driver mutations largely through higher mutation rates, while non-hypermutated tumors gain them through mutation-spectrum changes that reverse the germline mutation bias.\"},{\"question\":\"How do the mutation spectra of non-hypermutated tumors behave across tissues?\",\"answer\":\"Non-hypermutated tumors show a highly conserved mutation spectrum across tissues that consistently reverses the germline mutation bias.\"}]","Non-hypermutator cancers access driver mutations through reversals in germline mutational bias | PDF",1790014281,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50559e8ada85af0193fb06d9e485d1c6.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e57c67d1b98b539695342dde28fd75af.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1b5230e9cb80dc9cc7a04cc8acd5dfc.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6b599b3a5326c2ef1051936c0add1a9.webp",980,1268]